# Eric J. Lawitz, M.D. – FDA Inspection, Mar 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/eric-j-lawitz-md/5b8da1ab-02b8-41fb-acb6-70da768c1d0e
Source feed: FDA_Inspections

> FDA inspection 1006414 of Eric J. Lawitz, M.D., March 03, 2017. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006414
- Company Name: Eric J. Lawitz, M.D.
- Inspection Date: 2017-03-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1227747 - 2024-01-19
- FDA Inspection 837585 - 2013-06-24
- [FDA Inspection 797771 - 2012-08-24](https://www.keypedia.com/records/fda_inspections/eric-j-lawitz-md/c9ddd703-4ee6-4317-9094-a680af09a7f3)
- [FDA Inspection 662046 - 2010-05-14](https://www.keypedia.com/records/fda_inspections/eric-j-lawitz-md/70d8a856-26c6-40b1-9e85-1bbfd591f5e9)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/johann-m-fitch/201fa402-1e17-47f2-858c-7e862a10013d)

Company: https://www.keypedia.com/companies/eric-j-lawitz-md/02862e28-6e65-4b53-a9df-0bfa4a44dade

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c